Point72 Asset Management L.P. 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management L.P. | 3,114,107 6.700% | 1,131,546 (+57.07%) | Filing |
| 2022-02-14 4:35 pm Sale | 2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management L.P. | 1,982,561 5.100% | -665,463 (-25.13%) | Filing |
| 2021-03-22 5:02 pm Purchase | 2021-03-16 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management L.P. | 2,648,024 6.800% | 2,648,024 (New Position) | Filing |